Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9
Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9
Rodman & Renshaw 開始對奧麥羅製藥進行覆蓋,給予買入評級,宣佈目標價格爲9美元。
Rodman & Renshaw analyst Brandon Folkes initiates coverage on Omeros (NASDAQ:OMER) with a Buy rating and announces Price Target of $9.
Rodman & Renshaw分析師Brandon Folkes對奧麥羅製藥(納斯達克:OMER)發起覆蓋,給予買入評級,並宣佈目標價格爲9美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。